We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$104M
AUM Growth
+$40.1K
Cap. Flow
-$268K
Cap. Flow %
-0.26%
Top 10 Hldgs %
22.53%
Holding
63
New
1
Increased
2
Reduced
59
Closed
1

Top Buys

Rank Stock Value
1
ARE icon
Alexandria Real Estate Equities
ARE
+$1.9M
2
AES icon
AES
AES
+$1.44M
3
CI icon
Cigna
CI
+$69.6K

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$1.5M
2
SCHW
Charles Schwab
SCHW
+$448K
3
AVGO icon
Broadcom
AVGO
+$369K
4
KR icon
Kroger
KR
+$282K
5
CAH icon
Cardinal Health
CAH
+$188K

Sector Composition

Rank Sector Weight
1 Financials 25.19%
2 Healthcare 13.5%
3 Industrials 12.8%
4 Technology 10.14%
5 Consumer Staples 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$322B
$1.16M 1.11%
14,625
-136
-0.9% -$10.8K
SIRI icon
52
SiriusXM
SIRI
$9.66B
$1.12M 1.08%
48,935
-194
-0.4% -$4.17K
BEN icon
53
Franklin Resources
BEN
$17.2B
$1.11M 1.06%
46,503
-158
-0.3% -$3.26K
JNJ icon
54
Johnson & Johnson
JNJ
$631B
$1.08M 1.03%
7,041
-87
-1% -$13.4K
OHI icon
55
Omega Healthcare
OHI
$14.1B
$1.04M 0.99%
28,236
-294
-1% -$10.9K
EMN icon
56
Eastman Chemical
EMN
$8.36B
$1.01M 0.97%
13,491
-129
-0.9% -$10.1K
BBY icon
57
Best Buy
BBY
$17.9B
$999K 0.96%
14,889
-133
-0.9% -$9.04K
LYB icon
58
LyondellBasell Industries
LYB
$20.4B
$976K 0.94%
16,861
-154
-0.9% -$8.98K
TFC icon
59
Truist Financial
TFC
$63.4B
$953K 0.91%
22,163
-230
-1% -$9K
CAH icon
60
Cardinal Health
CAH
$57.3B
$756K 0.73%
4,502
-1,269
-22% -$188K
TROW icon
61
T. Rowe Price
TROW
$24.3B
$725K 0.7%
7,512
-74
-1% -$6.79K
CI icon
62
Cigna
CI
$73.5B
$686K 0.66%
2,075
+216
+12% +$69.6K
CCI icon
63
Crown Castle
CCI
$31.5B
-14,355
Closed -$1.5M

Similar funds

Weaver C. Barksdale & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Weaver C. Barksdale & Associates held 63 positions worth $104M, up 0.04% from $104M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 3.2%. Weaver C. Barksdale & Associates opened 1 new position and exited 1, leaving the 63-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q2 2025 buy was Alexandria Real Estate Equities: 25,548 shares worth $1.86M.
  • Weaver C. Barksdale & Associates added most to AES in Q2 2025, an estimated $1.44M increase.
  • Weaver C. Barksdale & Associates's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $448K.
  • Weaver C. Barksdale & Associates fully exited Crown Castle in Q2 2025, selling an estimated $1.5M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 23% of its $104M portfolio in Q2 2025.
  • Weaver C. Barksdale & Associates opened 1 new position and closed 1 in Q2 2025.
  • Weaver C. Barksdale & Associates's portfolio value rose 0.04% quarter-over-quarter to $104M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2025, filed 12 Aug 2025.